Month: March 2022

Las Vegas, Nevada, March 15, 2022 (GLOBE NEWSWIRE) — BioPower Operations Corporation, (OTC Pink: BOPO), in the process of changing its name to HYFI Corp (“HYFI’”), subject to clearance by FINRA, today announced that CEO, Troy MacDonald has been invited to present HYFI, a FinTech CeDeFi company at the Emerging Growth Conference on March 16, 2022. HYFI, (OTC: BOPO) invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. The next Emerging Growth Conference is presenting on March 16, 2022. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Troy MacDonald in real time. Mr. Troy MacDonald will make a presentation and...

Ian K. Patel, Citigroup veteran and Wharton MBA, Named CFO Louisville, Colorado, March 15, 2022 (GLOBE NEWSWIRE) — CEA Industries Inc. (NASDAQ: CEAD), a leader in controlled environment agriculture (CEA) systems engineering and technologies, announced today the appointment of Ian K. Patel as Chief Financial Officer and Treasurer of the Company, effective March 11, 2022. “Ian brings a proven track record of delivering results and accelerating growth, and our Board of Directors and I are thrilled to welcome him to the executive management team,” said Tony McDonald, CEA Industries Chairman and CEO. “Ian’s extensive experience advising and leading organizations in their finance activities will serve our company and our shareholders well.” Mr. Patel has extensive experience as a financial leader, having held several executive roles...

Acquisition Provides Ownership of the “Greens First” Brand and Further Validates Company’s Global Buy & Build Strategy MIAMI, March 15, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a leading developer, marketer, and manufacturer of nutritional and related products, announced today that it has executed a definitive agreement to acquire Ceautamed Worldwide, LLC and its affiliates, Wellness Watchers Global, LLC and Greens First Female, LLC (collectively “Ceautamed”), a vitamin and supplement company principally engaged in the development and distribution of a wide variety of nutritional products, including antioxidant rich supplements, plant-based protein, alkalizing nutrients and products designed for weight management. A.J. Cervantes, Jr., Chairman of Smart for Life,...

MONTREAL, March 15, 2022 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) announces today the acquisition by TC Media of Scolab Inc., a leader in the development of digital educational products. Scolab is known for Netmath, distributed in Canada in French and English, and Buzzmath, distributed in the United States. These products are used by thousands of students and teachers across North America. “Scolab is a visionary, innovative and dynamic company,” said Patrick Lutzy, President of TC Media. “This strategic acquisition enhances TC Media Books’ already strong digital offering. The co-existence of digital with print is essential today in our industry, and we are proud of our leadership in this area. This new step forward expands and diversifies our offering of digital educational products for the elementary...

With 15 years of experience in marketing and technology, GPOX rounds out its Senior Management Team with the addition of Mr. GarabrandtGPOPlus Names Bryan Garabrandt as VP of Sales Bryan Garabrandt – Vice President of Sales and Marketing and Chief TechnologistLAS VEGAS, NV, March 15, 2022 (GLOBE NEWSWIRE) —GPO Plus, Inc. (OTCQB: GPOX), a publicly traded company of diversified industry-specific Group Purchasing Organizations (GPOs), today announced Bryan Garabrandt’s official role with GPOX as the company’s Vice President of Sales and Marketing as well as its Chief Technologist. Mr. Garabrandt is a successful entrepreneur and a highly qualified marketing and technology professional with more than 15 years of experience in development, systems administration, online marketing, e-commerce, and proven leadership. Experienced...

CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics, today announces the mutual extension of a research agreement with University of Louisville Research Foundation (ULRF). The revised agreement expands the Company’s collaboration with the research institution to develop its ongoing RAS-F platform currently in the discovery stage for solid tumors through Q1 of 2023. “This extension of our agreement with ULRF represents our continued commitment to develop our exciting RAS-F platform by leveraging the ongoing relationship with this prestigious research institution,” commented Michael Poirier, Qualigen’s CEO....

CAPE CORAL, FL, March 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Legacy Education Alliance, Inc. (OTCQB: LEAI, the “Company”), has announced its strategic initiatives for the next 12 months, including to effect a Nasdaq uplisting. In connection with this initiative, Legacy Education is releasing a presentation outlining its business and Nasdaq uplisting strategy.  “Our goal is to combine Legacy’s history of real estate, financial and entrepreneurial education and mentoring with Coopersmith’s career-focused, low-cost degree completion program. We seek to build a sales and mentoring team that expands our universe of students, and helps guide them on their personal path to fulfillment of career and financial goals,” Legacy Education CEO Barry Kostiner said. “I am delighted to have the opportunity to present...

– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary endpoint of overall survival compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line treatment for advanced NSCLC patients without EGFR/ALK mutations – SHANGHAI, China and REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus” ), today announced the presentation of positive results and biomarker analysis from the pivotal study “CHOICE-01” (clinicaltrials.gov identifier# NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous...

Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that the company will release its 2021 fourth quarter and full year financial results after the market closes on Tuesday, March 29, 2022. Management will host a conference call and webcast at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on the company’s business. Details for the Conference Call:Date: March 29, 2022Time: 5:00 p.m. ET (2:00 p.m. PT)   Conference Audio–  Dial-in U.S. and Canada: (877) 451-6152–  Dial-in...